Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001209191-23-054968

General Counsel and Secretary sold 24,363 shares at $2.40 ($58,471)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TAHL CINDY General Counsel and Secretary 2023-11-09 Sale 10b5-1 −24,363 $2.40 $58,471 153,235 D
Open-market sales · 24,363 sh · avg $2.40 · $58,471
Loading xslF345X05/doc4.xml…